HiPP HA Stage 1 Combiotik and Enfamil Gentlease are both partially hydrolyzed whey formulas at the same clinical tier, positioned for atopic-risk prophylaxis and mild digestive sensitivity. But the two regulatory contexts (EU Regulation 2016/127 vs FDA 21 CFR 107) and brand philosophies produce very different compositions. HiPP HA keeps lactose as primary carb and adds a full Combiotik synbiotic system; Gentlease removes lactose, uses corn syrup solids, and skips bioactives entirely. Understanding this apples-to-apples pHF comparison helps parents see what US mass-market vs EU premium looks like at the same clinical tier.
HiPP HA: pHF 100% whey and lactose-primary and maltodextrin/glucose syrup and GOS prebiotic and 2 probiotic strains, RSPO palm, and DHA 14 mg, Metafolin, and EU lower iron, ~$40/600g. Gentlease: pHF 60:40 + corn-syrup primary (lactose removed) and no prebiotic, no probiotic, and palm, soy, and DHA 11.3 mg, folic acid, and US standard iron, ~$30/19.9 oz. Same pHF tier, opposite composition strategies.
Why this comparison matters
parents whose pediatrician has discussed a pHF trial (for atopic risk prophylaxis or mild fussiness attributed to protein digestion) typically get Gentlease at retail, often via WIC. Parents who learn about EU formula options sometimes discover HiPP HA as the "European gentle option" and wonder if it's simply a cleaner version of the same product. It isn't, same clinical tier, different formulations. HiPP HA retains lactose (which Gentlease removes), adds a full synbiotic (which Gentlease omits), and uses EU-style micronutrient fortification (Metafolin and lower iron). This isn't "EU = better", it's "EU and US pHF approaches solve the same clinical problem differently."
At a glance
| Dimension | HiPP HA Stage 1 Combiotik | Enfamil Gentlease |
|---|---|---|
| Manufacturer | HiPP GmbH (Germany) | Reckitt / Mead Johnson (US) |
| Regulation | EU Regulation 2016/127 | FDA 21 CFR 107 |
| Clinical category | Partial hydrolysate (pHF) | Partial hydrolysate (pHF), same tier |
| FDA-registered | No (personal import enforcement discretion) | Yes |
| Protein | Partially hydrolyzed 100% whey | Partially hydrolyzed nonfat milk and whey |
| Whey:casein | 100:0 (whey-only) | 60:40 |
| Primary carbohydrate | Lactose (primary) and maltodextrin and glucose syrup secondary | Corn syrup solids (primary, lactose reduced) |
| Prebiotic | GOS (Combiotik) | None |
| Probiotic | L. fermentum and L. rhamnosus (Combiotik) | None |
| HMO | None | None |
| Iron | 0.5 mg/100 ml (EU standard) | 1.2 mg/100 ml (US standard) |
| Folate | Metafolin (bioactive L-methylfolate) | Folic acid |
| DHA | Fish oil, ~14 mg/100 ml | Algal (Crypthecodinium), ~11.3 mg/100 ml |
| Fat blend | RSPO-certified palm and rapeseed, sunflower, and coconut | Palm, soy, coconut, and safflower |
| Soy oil | No | Yes |
| Red flags | Palm (RSPO-certified), maltodextrin | Corn syrup solids |
| Fat-blend notes | None | palm oil, soy |
| Format | 600 g tin | 19.9 oz (~564 g) can |
| Typical price (US) | ||
| WIC coverage | No (not FDA-registered) | Very broad US state coverage |
| US availability | Personal import only | Broad US retail |
Visual generated with Napkin AI, editorial review by María López Botín. See methodology for our use policy.
Compositional differences that actually matter
1. Lactose retention vs removal: the biggest philosophical difference
HiPP HA: retains lactose as primary carbohydrate, with maltodextrin and glucose syrup as secondary. The thesis: lactose supports bifidogenic fermentation (favorable for the Combiotik probiotic strains), and most infants without documented lactose issues tolerate it well even in the pHF context.
Gentlease: removes most lactose, replacing it with corn syrup solids as primary. The thesis: reducing lactose reduces fermentation- related gas and discomfort, which drives the "gentle" marketing effect.
This is the single biggest composition difference. For a parent who thinks a pHF would help (protein digestion sensitivity, atopic risk) but doesn't specifically need lactose reduction, HiPP HA effectively solves the protein problem without altering carbohydrate composition, closer to breast-milk carbohydrate profile. For a parent whose baby's issues seem specifically lactose-linked, Gentlease's reduced-lactose approach addresses that more directly.
Neither approach is universally "correct", the EU regulatory baseline explicitly favors lactose-primary in standard Stage 1 formula; US FDA allows corn-syrup-primary. See our infant lactose intolerance explainer — true primary lactose intolerance in infants is extremely rare.
2. Bioactive layer: Combiotik vs nothing
HiPP HA: Combiotik system, L. fermentum CECT5716 and L. rhamnosus probiotics and GOS prebiotic. Multi-strain and prebiotic synbiotic. HiPP's signature bioactive across the Combiotik line.
Gentlease: no probiotic, no prebiotic, no HMO. Gentlease's formulation priorities are partial hydrolysis and reduced lactose only, not bioactive fortification.
This is a very meaningful difference. For parents considering a pHF for atopic-risk prophylaxis (where microbiome support alongside hydrolysis may compound benefit), HiPP HA's synbiotic addition is research-backed. For parents whose team sees lactose reduction as the primary intervention, Gentlease's simpler composition fits.
For US pHF and bioactive combined, Gerber Good Start SoothePro is the closest US option (pHF and 2'-FL HMO and B. lactis Bb-12 probiotic) — see our Gerber SoothePro vs Enfamil Gentlease comparison.
3. Protein ratio: 100% whey vs 60:40
HiPP HA: 100% whey, partially hydrolyzed. Whey-only profile is fast-digesting and standard for EU pHF formulas.
Gentlease: 60:40 whey:casein, both partially hydrolyzed. Casein fraction retained at intermediate-size fragments.
Both are partial hydrolysates; the ratio choice reflects different regulatory and formulation norms. Neither is clinically superior for a healthy infant; 100% whey may digest marginally faster but differences are small.
4. Iron and folate: EU vs US standards
HiPP HA: iron 0.5 mg/100 ml (EU standard, intentionally lower because research suggests excess iron may not benefit and may harm microbiome); folate as Metafolin (bioactive L-methylfolate, bypasses MTHFR genetic variants affecting ~40-60% of population).
Gentlease: iron 1.2 mg/100 ml (US standard, ~2.4× higher); folate as folic acid (traditional synthetic form).
These are meaningful long-term differences. Higher iron in US formulas follows historic fortification standards; EU explicitly reduces iron based on research. Metafolin is a bioactive form bypassing genetic variants; folic acid is the standard form. For parents specifically valuing EU-style fortification: HiPP HA.
5. Fat blend: RSPO palm vs palm and soy
HiPP HA: RSPO-certified palm and rapeseed, sunflower, and coconut. No soy oil. RSPO certification is the EU standard for sustainable palm sourcing.
Gentlease: palm olein, soybean, coconut, and safflower. No RSPO labeling. Contains soy oil.
For parents prioritizing sustainable palm sourcing AND avoiding soy oil entirely, HiPP HA has documented advantages. Gentlease's soy oil is in the fat blend (trace protein, not primary protein), but for families with strong soy avoidance preference, it's a consideration.
6. DHA: HiPP HA higher
HiPP HA ~14 mg DHA / 100 ml vs Gentlease ~11.3 mg / 100 ml. HiPP HA's higher DHA reflects EU upper-range breast-milk targeting. Both meet regulatory adequacy.
7. Price and availability
HiPP HA: ~$1.89/oz via US personal import, roughly 26% more expensive per-oz than Gentlease. Requires trusted EU reseller (Organic's Best and similar); not at US retail. Shipping adds 3-7 business days typically.
Gentlease: ~$1.50/oz at US retail, broadly available at Target, Walmart, CVS, Amazon. Very broadly WIC-covered in US states (often the primary pHF covered). Effective cost for WIC-qualifying families is $0.
For families relying on WIC: Gentlease is effectively free; HiPP HA is out-of-pocket ~$40 per tin. For families paying retail: Gentlease is ~26% cheaper.
8. Recall history
HiPP HA: no HA-specific recall in recent history. HiPP's quality-control record is generally strong across the Combiotik line.
Gentlease (Reckitt): no active recall on Gentlease. Reckitt had historical lot-level recalls across Enfamil lines; not affected by Abbott's 2022 Sturgis event.
Regulatory framework
HiPP HA: EU Regulation 2016/127 and EU food safety. US personal import legal under FDA enforcement discretion; not FDA-registered. WIC coverage unavailable.
Gentlease: FDA 21 CFR 107, standard infant formula classification (not exempt under 107.30: Gentlease is pHF, not eHF). Broad WIC coverage.
Important clinical note: neither HiPP HA nor Gentlease is indicated for diagnosed CMPA. That requires extensively hydrolyzed (eHF) formulas like Nutramigen or Similac Alimentum, or amino acid formulas if eHF fails. See our CMPA and formula explainer.
Real-world parent experience
Following site methodology, observations come from US and EU parent feedback. Not clinical recommendations. Where my own feeding observations are referenced, they are clearly labeled as parent-experience notes; manufacturer claims and regulatory data are cited separately so the source weight stays explicit.
Smell and taste. HiPP HA has a neutral, mild smell with slight lactose sweetness, typical of EU pHF Combiotik formulas. Gentlease is sweeter (corn-syrup-solids register sweeter than lactose to infant palate) with a more medicinal profile.
Stool consistency. HiPP HA produces typical standard-formula soft/formed stool with Combiotik-supported gut motility. Gentlease produces softer, more frequent, occasionally greener stool (typical of reduced-lactose corn-syrup formulas).
The "less gas" effect. Gentlease typically delivers faster observable "less gassy baby" effect because the lactose reduction directly reduces fermentation load, but this can be misleading (most newborn "gas" is normal adjustment, not lactose issues). HiPP HA's effect is more about protein digestion ease and Combiotik microbiome support, with less dramatic day-to-day symptom shift.
Switching between them. Multiple simultaneous changes: carbohydrate (lactose ↔ corn-syrup), probiotic/prebiotic add/remove, fat blend (RSPO palm ↔ standard palm and soy), micronutrient fortification (Metafolin ↔ folic acid, EU iron ↔ US iron). Use a 6-8 day gradual transition (longer than typical brand-switch). Going HiPP HA → Gentlease: sweeter taste, softer stool, microbiome support removed. Going Gentlease → HiPP HA: less sweet, more typical stool pattern, microbiome support added.
Verdict: when each applies
Pick HiPP HA Stage 1 Combiotik if:
- You value lactose-primary composition (closer to breast milk) with pHF protein
- You want Combiotik synbiotic (GOS and probiotics) alongside pHF
- You value EU-style micronutrient fortification (Metafolin and lower iron)
- You want to avoid soy oil
- You can source via personal import
Pick Enfamil Gentlease if:
- Cost matters, ~21% cheaper per-oz at retail
- WIC coverage matters (Gentlease broadly covered; HiPP HA not)
- Your pediatric team specifically recommends reduced-lactose pHF approach
- Your baby's issues appear specifically lactose-linked (not pure protein sensitivity)
- Pediatrician familiarity matters (Gentlease is the most-prescribed US pHF)
Pick neither if:
- Your baby has diagnosed CMPA, pHF is not appropriate; eHF (Nutramigen or Similac Alimentum) is required
- You want US pHF with HMO and probiotic combined, consider Gerber Good Start SoothePro
- You want lactose-primary US standard (not pHF), consider Enfamil NeuroPro (lactose and MFGM and 2'-FL and GOS)
- You want US-based EU-style composition (USDA Organic, lactose, and no soy), consider Bobbie Original
What you can't infer from this comparison
Both are safe pHF formulas for their respective regulatory markets. Neither is indicated for diagnosed CMPA. The EU-vs-US composition divergence is real (lactose retention, synbiotic, and RSPO palm vs corn-syrup, no bioactives, standard palm, and soy) but doesn't translate to "EU = better" universally, each composition is designed for its regulatory and commercial context. For parents specifically valuing EU-style composition and can manage personal import, HiPP HA is compelling. For parents prioritizing cost, WIC access, and US clinical familiarity, Gentlease fits.
Frequently asked questions
Is HiPP HA or Enfamil Gentlease better for a fussy baby?
Is HiPP HA's Combiotik really meaningful compared to plain pHF?
Can I use HiPP HA in place of Gentlease for WIC purposes?
Is HiPP HA's lactose retention better than Gentlease's lactose reduction?
Does HiPP HA have Metafolin and Gentlease have folic acid?
Is the price difference worth it for HiPP HA?
Can I use either for diagnosed CMPA?
Can I switch between them?
Related reading
- HiPP brand hub
- Enfamil brand hub
- HiPP HA Combiotik vs Nutramigen, pHF vs eHF category difference
- Enfamil Gentlease vs Similac Pro-Total Comfort. US pHF head-to-head
- Gerber Good Start SoothePro vs Enfamil Gentlease. US pHF and bioactive vs category leader
- Is it legal to buy European formula in USA
- EU infant formula regulation
- Hydrolyzed whey explainer
- GOS explainer
- Probiotics in formula
- Corn syrup solids explainer
- Infant lactose intolerance explainer
Primary sources
- HiPP GmbH, manufacturer product information. hipp.de
- Enfamil / Reckitt (Mead Johnson), manufacturer product information. enfamil.com
- EU Regulation 2016/127. EU compositional requirements for infant formula. eur-lex.europa.eu
- FDA 21 CFR Part 107. US infant formula regulation. ecfr.gov
- EFSA Scientific Opinion on compositional requirements for infant formula. efsa.europa.eu
This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.

